Home›Companies›Biotech & Pharma›Dualitas Therapeutics

Dualitas Therapeutics, Inc.

Updated Oct 27, 2026·Latest SEC filing Nov 18, 2025·Suggest an edit

About Dualitas Therapeutics

Dualitas Therapeutics is a private company based in South San Francisco, California, incorporated in 2023 in Delaware. It has reported $32,599,997 raised in one offering on Form D since November 2025.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Jul 7, 2025Nov 18, 2025$32,599,997of $66.5M target7$4.6MEquityRule 506(b)Form D ↗

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Dualitas Therapeutics's Form D filed Nov 18, 2025.

TH
FH
Forbes Huang
Executive officer
AL
Alicia Levey
Director
MR
Michael Ross
Director
GL
Greg Lazar
Executive officer
NW
Neil Weir
Director
MM
Mark McDade
Director
RM
Richard Murray
President and director
NT

Sources

  1. SECDualitas Therapeutics, Inc. filing history